First ever drug found to slow Alzheimer’s submitted for approval
1 year, 6 months ago

First ever drug found to slow Alzheimer’s submitted for approval

The Telegraph  

The first ever drug found to slow Alzheimer’s has gone to Britain’s regulators for approval. The findings of the phase-three clinical trial were the first to ever show a drug can slow Alzheimer’s. Richard Oakley, Associate Director of Research at Alzheimer’s Society, said: “This is exciting progress and means that we could hear if lecanemab has been approved by early next year. The MHRA will be balancing the safety and potential benefit of lecanemab, to make the best decision for people living with early Alzheimer’s disease.

History of this topic

Tens of thousands to be recruited into Alzheimer’s trials after landmark drug rejected
2 months ago
UK regulator approves second Alzheimer's drug in months but government won't pay for it
2 months ago
Alzheimer’s wonder drug blocked on NHS over cost
2 months ago
Second Alzheimer’s drug expected to be blocked for NHS use
4 months ago
What are the symptoms and treatments for Alzheimer’s – as new drug is rejected
4 months ago
Weight-loss drug ‘could slow progression of Alzheimer’s disease’
4 months, 3 weeks ago
European committee says Alzheimer’s treatment Leqembi shouldn’t get marketing approval
4 months, 4 weeks ago
Eli Lilly Alzheimer's drug approved by US FDA
5 months, 3 weeks ago
FDA approves another Alzheimer's drug that can slow disease in its early stages
5 months, 3 weeks ago
FDA approves a second Alzheimer’s drug that can modestly slow disease
5 months, 3 weeks ago
Alzheimer’s drug that can slow disease gets backing from FDA advisers
6 months, 2 weeks ago
It’s the first drug shown to slow Alzheimer’s. Why is it off to a slow start?
8 months, 1 week ago
FDA will take a deeper look into the safety and effectiveness of Lilly experimental Alzheimer’s drug
9 months, 2 weeks ago
Biogen will stop selling its controversial Alzheimer’s drug Aduhelm
10 months, 3 weeks ago
Lecanemab drug trial to examine if it can slow progress of Alzheimer's disease
1 year, 2 months ago
A new treatment for Alzheimer’s offers hope—but raises questions, too
1 year, 5 months ago
Second Alzheimer’s drug in pipeline can slow the disease by a few months but with safety risk
1 year, 5 months ago
Second Alzheimer’s drug in pipeline can slow the disease by a few months but with safety risk
1 year, 5 months ago
New Alzheimer’s wonder drug ‘can slow disease progression by 60pc’
1 year, 5 months ago
New drug for Alzheimer's gives hope and ushers in new era in fighting the disease, says doctor
1 year, 5 months ago
First drug to slow Alzheimer's progression approved in US | 5 points
1 year, 5 months ago
US FDA grants standard approval of Eisai, Biogen Alzheimer's drug
1 year, 5 months ago
Alzheimer: This Country Has Approved New Drug That Will Combat Cognitive Decline
1 year, 5 months ago
Alzheimer’s drug Leqembi has full FDA approval now and that means Medicare will pay for it
1 year, 5 months ago
Alzheimer's drug Leqembi gets full FDA approval. Medicare coverage will likely follow
1 year, 5 months ago
Alzheimer’s drug Leqembi has full FDA approval now and that means Medicare will pay for it
1 year, 5 months ago
FDA panel unanimously endorses Lecanemab for Alzheimer's treatment, offering hope to millions
1 year, 6 months ago
Alzheimer's drug gets FDA panel's backing, setting the stage for broader use
1 year, 6 months ago
Alzheimer’s drug gets FDA panel’s backing, setting the stage for broader use
1 year, 6 months ago
Breakthrough Alzheimer’s drugs could be blocked by NHS, campaigners warn
1 year, 6 months ago
Benefits of lecanemab, a new Alzheimer's drug, unclear for patients of color : Short Wave : NPR
1 year, 9 months ago
Why a new Alzheimer’s drug is having a slow US debut
1 year, 10 months ago
EXPLAINER: New drug slows Alzheimer’s but comes with caveats
1 year, 11 months ago
US: FDA approves anti-Alzheimer's drug
1 year, 11 months ago
US approves Alzheimer’s drug that modestly slows disease
1 year, 11 months ago
U.S. approves Alzheimer’s drug that modestly slows disease
1 year, 11 months ago
Alzheimer's drug breakthrough 阿尔茨海默病治疗药物获重大突破
1 year, 11 months ago
Explained | Will new drug slow progress of Alzheimer’s?
2 years ago
Is the new drug lecanemab a breakthrough for Alzheimer’s?
2 years ago
Drug slows Alzheimer’s but can it make a real difference?
2 years ago
Alzheimer's drug from Eisai and Biogen slows cognitive decline, side-effects in focus
2 years ago
Breakthrough: A drug slows Alzheimer’s by 5 months, but will it make a big difference?
2 years ago
New drug appears to slow Alzheimer’s, but can it make a real difference?
2 years ago
Drug that reverses dementia will be wasted without better diagnosis rates, experts warn
2 years ago
Alzheimer’s drug shows promise in early results of study
2 years, 2 months ago
'Huge breakthrough' for Alzheimer's
2 years, 2 months ago
FDA trims use of contentious Alzheimer’s drug amid backlash
3 years, 5 months ago
Alzheimer’s disease drug: FDA narrows prescribing information
3 years, 5 months ago
Does new Alzheimer’s drug work? Answers may miss 2030 target
3 years, 5 months ago

Discover Related